Sponsored Content

Rebranded Astaxin® now available in pharmacies

15 Feb 2024

New-look astaxanthin-containing supplement launched in retail outlets in Sweden and Norway

Nacka (Sweden), January 2024 – AstaReal, global pioneer in production and research of natural algal astaxanthin, has launched a rebranded version of its finished formulation Astaxin® for consumers in Sweden and Norway. In addition to online stores and health food stores, the supplement is also now available in selected pharmacies.

The proven formula of Astaxin® – now with a new minimalist Nordic product design – combines microalgae-based astaxanthin with vitamins C and E. It is delivered in gelatin capsules in two different product sizes (60 and 120 capsules). With a recommended intake of one to two capsules daily, the supplement provides cell protection and supports an active and healthy lifestyle. Vitamin C and E protect cells against oxidative stress, which is validated by the health claim on the package.

Additionally, vitamin C contributes to the normal functioning of the immune system and reduces fatigue and exhaustion. Each capsule also contains 4 mg of astaxanthin for additional health support.

AstaReal launched Astaxin® Original nearly 30 years ago as the first human dietary supplement containing a natural source of astaxanthin. With the rebranding, the Swedish astaxanthin pioneer has given a luxurious new feel to its well-established product. Nutraceutical companies got a first glance of Astaxin® at AstaReal’s booth at Fi Europe in Frankfurt at the end of 2023. Furthermore, the company plans to launch a vegan version of Astaxin® for the European market in the near future, following its launch in China.

Rebranded Astaxin® now available in pharmacies
Image Copyright AstaReal AB, photograph Malin Lindner

Peter Ahlm, Head of Marketing & Sales at AstaReal, explains: “Astaxin® plays a key role in our mission to support the health of humans and wellbeing of the planet. Alongside our finished formulations for the retail market, we offer various bulk products of astaxanthin, all derived from sustainably cultivated microalgae Haematococcus pluvialis. AstaReal® astaxanthin is one of nature’s most powerful antioxidants with scientifically proven health benefits. The ingredient is highly future-proof, as it matches consumer demand for natural sustainable, and plant-based ingredients.”

About AstaReal AB

AstaReal AB is part of the AstaReal Group, which is a wholly owned subsidiary of the Japanese pharmaceutical company Fuji Chemical Industries Co. Ltd. The Group uses AstaReal® as the global brand name for its natural algal astaxanthin products. As a worldwide pioneer and expert in natural astaxanthin production, R&D and clinical science, the company offers a variety of specialized astaxanthin formats to help meet customer requirements when developing dietary supplements, sports nutrition products, cosmetics and animal feed.

AstaReal AB is ISO 9001, HACCP, FSSC 22000, Informed Ingredient, Kosher, and Halal certified, and carries the Vegan Trademark for its bulk products. The company’s roots trace back to the prestigious Uppsala University, Sweden. Successfully proven benefits of natural astaxanthin for human health encouraged the scientists there to establish AstaReal’s first production facility in Gustavsberg, Sweden, in the early 1990s. In 1995, AstaReal AB launched Astaxin® – the first human nutritional supplement containing a natural source of astaxanthin. Today, AstaReal produces natural astaxanthin at facilities in Sweden and the USA. AstaReal AB offers private labelling, and is open to co-branding and joint product development.

For further information, please visit: https://www.astareal.se

Read More

Related news

PharmaLinea’s iron supplement delivers improvements in  hemoglobin comparable to ferrous sulfate with fewer side  effects

PharmaLinea’s iron supplement delivers improvements in hemoglobin comparable to ferrous sulfate with fewer side effects

23 Feb 2026

PharmaLinea, a Slovenian developer and manufacturer of private label food supplements, has announced the completion of a clinical study evaluating its finished formulation for iron deficiency.

Read more 
LomaChelateX® – power in magnesium bisglycinate

LomaChelateX® – power in magnesium bisglycinate

12 Feb 2026

Gentle and effective: magnesium bisglycinate is setting a new standard. Through its LomaChelateX® brand, Dr. Paul Lohmann® delivers magnesium bisglycinate and a broad range of fully reacted mineral bisglycinates made in Germany.

Read more 
Fucoidan leader reports record production

Fucoidan leader reports record production

22 Jan 2026

The global leader in fucoidan science, Marinova Pty Ltd, reported record annual fucoidan production for 2025. The company's total production volume has more than doubled over the past three years.

Read more 
India Honours Ashwagandha with Commemorative  Postal Stamp at WHO Global Summit

India Honours Ashwagandha with Commemorative Postal Stamp at WHO Global Summit

6 Jan 2026

HYDERABAD, December 20, 2025 – India’s Prime Minister Mr. Narendra Modi, alongside WHO Director-General Dr. Tedros Adhanom Ghebreyesus, released a commemorative postal stamp honoring ashwagandha at the recently concluded Second WHO Global Traditional...

Read more 
PharmaLinea delivers actionable 2026 insights at the first ever NutraLoop™ Summit

PharmaLinea delivers actionable 2026 insights at the first ever NutraLoop™ Summit

22 Dec 2025

PharmaLinea held its first-ever NutraLoop™ Summit this December. The virtual event featured 12 speakers from companies such as IQVIA, NHCO, Radicle Science, and BeyondBrands, who provided comprehensive insights across the scientific and commercia...

Read more 
FrieslandCampina strengthens its global protein position with acquisition of Wisconsin Whey Protein

FrieslandCampina strengthens its global protein position with acquisition of Wisconsin Whey Protein

11 Dec 2025

Royal FrieslandCampina N.V. intends to acquire Wisconsin Whey Protein, a respected producer of whey protein isolates in the United States. Wisconsin Whey Protein will become part of FrieslandCampina Ingredients, a global leader in proteins and prebioti...

Read more 
dsm-firmenich names ‘Frosted Star Anise’ as Flavor of the Year 2026, capturing a global desire for warmth and freshness

dsm-firmenich names ‘Frosted Star Anise’ as Flavor of the Year 2026, capturing a global desire for warmth and freshness

11 Dec 2025

Kaiseraugst (Switzerland), Maastricht (Netherlands), December 5, 2025  dsm-firmenich, innovators in nutrition, health, and beauty, announces ‘Frosted Star Anise’ as its Flavor of the Year for 2026. This...

Read more 
Balchem Makes Strategic Investment in U.S. Food Ingredients Market with New Microencapsulation Manufacturing Facility

Balchem Makes Strategic Investment in U.S. Food Ingredients Market with New Microencapsulation Manufacturing Facility

11 Dec 2025

Montvale, New Jersey, (10 December, 2025) – Balchem, a leading global manufacturer of specialty ingredients for human nutrition and health, is pleased to announce the development of a new, high-capacity man...

Read more 
Fucoidan specialist takes out top international health award

Fucoidan specialist takes out top international health award

4 Dec 2025

Marinova has been named Australia's most outstanding contributor to international health in the nation's prestigious Australian Export Awards.

Read more 
Prayon inaugurates its new SHMP production unit in Engis

Prayon inaugurates its new SHMP production unit in Engis

1 Dec 2025

Prayon inaugurates its new SHMP production unit in Engis, a major investment that strengthens its position in the food and technical phosphates market

Read more